BioSpace News Archive

99.5% reduction in annualized rate of vaso-occlusive crises (VOC) and acute chest syndrome (ACS) in Group C patients with a history of VOCs and ACS (n=14) who had at least six months follow-up

Transparency Market Research has published a new report titled ‘Pigmentation Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026’, according to which, the global pigmentation disorders treatment market was valued at US$ 5,225.0 Mn in 2017 and is projected to reach US$ 9,268.6 Mn by 2026, expanding at a CAGR of 6.8% during the forecast period of 2018 to 2026.

Transparency Market Research has published a new report titled, “Anticoagulant Reversal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Transparency Market Research has published a new report titled, “Blood Group Typing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 to 2026.” According to the report, the global blood group typing market was valued at US$ 1,500.0 Mn in 2017 and is projected to reach US$ 3,556.0 Mn by 2026, expanding at a high CAGR of 10.3% from 2018 to 2026.

The global animal parasiticides market was valued at US$ 5,606.8 Mn in 2017 and is projected to expand at a cumulative annual growth rate of 5.5% from 2018 to 2026 according to a new report published by Transparency Market Research titled “Animal Parasiticides Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

The growth of the global sarcoma biopsy market relies on advancements in cancer therapies.

The drive for application in life sciences tools between life science researcher stems from the need for bioinformatics for unearthing a diverse array of scientific data.

Safety Profile Consistent with Previously Published Phase 2 Data for Mitapivat in Patients with Pyruvate Kinase Deficiency or Expected in the Context of Sickle Cell Disease

The global rheumatoid arthritis drugs market was valued at US$ 19597.4 Mn in 2016.

The global viral vector and plasmid DNA testing services market is estimated to be influenced by the increased innovation and spending in research and development activities relating to the field.